Results 271 to 280 of about 402,660 (356)

Methylphenidate use in hyperphagic Prader-Willi syndrome: A clinical note. [PDF]

Indian J Psychiatry
Saruhan K.
europepmc   +1 more source

Continuous Apomorphine Infusion in Multiple System Atrophy Real‐World Insights From a French Nationwide Retrospective Cohort

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Continuous subcutaneous apomorphine infusion (CSAI) is effective in Parkinson's disease but has not been evaluated in multiple system atrophy (MSA). Objective To assess the 6‐month efficacy and tolerability of CSAI in MSA patients. Methods French multicenter retrospective registry‐based analysis of CSAI use in MSA.
Simon Lamy, Frederique Leh, Alexandra Foubert‐Samier, Soizic Leguy Bonnet, Guillaume Baille, Margherita Fabbri, Margaux Dunoyer, Lise Mantisi, Caroline Giordana, Anaïs El Ouartassi, Olivier Rascol, Wassilios G. Meissner, David Bendetowicz, Marie Vanel, David Grabli, Fabienne Ory‐Magne, Sophie Drapier   +16 more
wiley   +1 more source

Varying patterns of association between cortical large-scale networks and subthalamic nucleus activity in Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Kohl O, Gohil C, Sure M, Schnitzler A, Florin E.   +4 more
europepmc   +1 more source

Homogenous Cell Transplantation Trials in Parkinson's Disease: A Systematic Review and Meta‐Analysis

Movement Disorders Clinical Practice, EarlyView.
Abstract Background The transplantation of homogenous cells has emerged as an investigational strategy for Parkinson's disease (PD), offering an alternative to symptomatic treatment. Objective We performed a systematic review and meta‐analysis to assess its clinical efficacy and safety.
Nolan Reinisch, Athena Mancini, Adham Elsherbini, Jason Yuen, Andres Lozano   +4 more
wiley   +1 more source

Glucagon-like Peptide-1 and Dual GIP/GLP-1 Receptor Agonists in Brain: Exploring the Expanding Role and Safety in Neuropsychiatry. [PDF]

Int J Mol Sci
Tudosie AC, Marin LM, Popa SG, Golli AL.
europepmc   +1 more source

From Neuroadaptation to Neuroprogression: Rethinking Chronic Cocaine Exposure Through a Model of Cocaine-Related Cerebropathy. [PDF]

J Clin Med
Carbone MG, Maremmani I, Della Rocca F, Gastaldello G, Mazzetto L, Bellini A, Rizzato R, Miccichè R, Tripodi B, Tagliarini C, Dematteis M, Maremmani AGI.   +11 more
europepmc   +1 more source

POLG‐Related Parkinsonism with Good Response to Deep Brain Stimulation

Movement Disorders Clinical Practice, EarlyView.
Evdokia Efthymiou, Fabian Büchele, Sujitha Mahendran, Lennart Stieglitz, Bettina Balint   +4 more
wiley   +1 more source

Micro- and nanoplastics influences in Parkinson's disease: lessons from human stem cell models. [PDF]

Front Toxicol
Muhammad KN, Woodlief T, Wu X.
europepmc   +1 more source

Age-related dopaminergic integrity in the SNpc and VTA: morphometric and volumetric findings in marmoset (<i>Callithrix jacchus</i>). [PDF]

Front Neuroanat
Azambuja MMO, de Santana NNM, Morais PLAG, Vasiljevic GAM, Cavalcante JS, Bhagwandin A, Cavalcanti JRLP, Engelberth RC.   +7 more
europepmc   +1 more source

The potential of neuromelanin-sensitive MRI in psychiatric disorders. [PDF]

Neurosci Appl
Neutelings E, van de Giessen E, de Haan L, van der Pluijm M.   +3 more
europepmc   +1 more source